Competence Centre TEDD
Education, R&D and networking platform promoting the application of 3D organotypic technologies for therapies development, with the core goal of replacing animal experimentation according to 3Rs (Replacement, Reduction and Refinement).
At three days exhibition Biointerfaces International 2022 & TEDD Annual Meeting 2022 on 13 - 15 September 2022 TEDD Partners receive 30% discount on exhibition fee CHF 1500 instead CHF 2300.
For more information about the exhibition, please contact us at email@example.com.
For more information about sponsorship, please contact us at firstname.lastname@example.org.
The visits drew close to 40 participants from industry and academia.The participants had the opportunity to visit our laboratories on various tours on the topics of automated organoid handling, bioprinting, bioprocess technologies and microphysiological systems in toxicology.
TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, scientific reviews and we provide a platform to generate research consortia, projects and grant applications.